PerkinElmer
check quantity

OptiPlate-384, White Opaque 384-well Microplate, Case 50

384-well microplate for use in time-resolved fluorescence, luminescence, Alpha, and radiometric assays. This OptiPlate™ is white and made of polystyrene.

Part Number
Unit Size
List Price
Your Price
Quantity
6007290
Case of 50
307.00 USD
 
more
6007299
Case of 200
1164.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

The OptiPlate is one of the most versatile microplates offered by PerkinElmer, used in many different applications, assays, and instruments. The optimized well design and high quality plastics provides low background and crosstalk.

OptiPlates are uniquely engineered to be the same height for 96-, 384-, and 1536-well plates, and with extraordinary well flatness for ease in automation.

Leveraging years of assay and instrument experience in plate detection, PerkinElmer designs better microplates for better performance that guarantees better results for all PerkinElmer applications.

Packaging Notes:

  • Cases of 50 are packaged as 2 sleeves of 25 plates each. Each sleeve as 5 wraps with 5 plates.
  • Cases of 100 are packaged as 4 sleeves of 25 plates each.
  • Cases of 200 are packaged as 8 sleeves of 25 plates each. Each sleeve as 5 wraps with 5 plates.

Well Plate Dimensions

Well format: 384-well

Number of Rows 16
Number of Columns 24
Well volume 105 µL
Recommended working volume 24 µL – 90 µL
Height (mm) 14.35
Length (mm) 127.76
Width (mm) 85.47
Well diameter (mm) 3.65
Well depth (mm) 10.4
A1 to top offset (mm) 9
A1 to side offset (mm) 12.1
Well-to-well spacing (mm) 4.5

Specifications

Automation Compatible Yes
Coating Treatment Untreated
Color White
Detection Method Luminescence, Alpha, Time-Resolved Fluorescence (TRF & TR-FRET), Radiometric
Material Polystyrene
Product Brand Name OptiPlate
Shipping Condition Ambient
Sterile No
Unit Size Case of 50
Wells Number 384 well plate
Resources, Events & More
  • All

Application Note

Measuring PD-L1 Expression in Breast Cancer Cell Lines with AlphaLISA

Too many candidates, too little time. The lack of robust, rapid, high-throughput assays to identify and qualify potential therapeutic targets in areas such as cancer research continues to cost valuable time. What if you could increase assay throughput without compromising sensitivity, obtain more data points from each sample and eliminate tedious wash steps? Find out how AlphaLISA® assay technology, combined with the EnVision® multimode plate reader, provides a fast, powerful, homogeneous platform for screening potential inhibitors of PD-L1 (a protein associated with breast cancer tumor cells) expression in human cells.

PDF 4 MB
Utilizing AlphaLISA Technology to Screen for Inhibitors of the CTLA-4 Immune Checkpoint

Immune checkpoints serve a critical role in the immune system to prevent autoimmunity and manage the degree and duration of an immune response. Cytotoxic T-Lymphocyte-associated protein 4 (CTLA-4 or CD152) is an inhibitory transmembrane protein involved in an immune checkpoint of significant interest for therapeutic development. When CTLA-4 is expressed and competes with CD28, the immune system response is downregulated. As a result of this immune system response balance, immune checkpoints provide an opportunity for therapeutic intervention to modulate immune system activity.

There is a high demand for new drugs to block CTLA-4 and modulate immune system activity. In this application note, we demonstrate how to screen for novel CTLA-4 blocking drugs by utilizing the AlphaLISA CTLA-4/CD80 binding assay.

PDF 1 MB